dinitrophenol glutathione

dinitrophenol glutathione Thermoregulation in mitochondria: ∆ T = temperature change, q = heat S-(2,4-Dinitrophenyl)-Glutathione (Dinitrophenyl-S-Glutathione, GS-DNP, NSC 131112,

Name: dinitrophenol glutathione Thermoregulation in mitochondria: ∆ T = temperature change, q = heat S-(2,4-Dinitrophenyl)-Glutathione (Dinitrophenyl-S-Glutathione, GS-DNP, NSC 131112,
Brand: southroadsurgery.com.au
SKU: 9833603203
Price: 28.93 USD
Availability: InStock
Rating: 4.550800000000001 (10 reviews)

S (2,4 Dinitrophenyl) Glutathione (Dinitrophenyl S Glutathione, GS DNP, NSC 131112, NSC 638615, CAS Number: 26289 39 4) Cayman Chemical dinitrophenol glutathione Conjugating uncoupler compounds with hydrophobic hydrocarbon chains to achieve adipose tissue selective drug accumulation L Glutathione reduced Metabolic pathways of 2,4 dinitrophenol (2,4 DNP) in humans. NADPH Download Scientific Diagram Involvements of energy metabolism, disease defense system and cell wall integrity in 2,4 dinitrophenol and adenosine triphosphate mediated energy state modulating disease occurrence in fresh longan incurred by Phomopsis longanae Chi ScienceDirect 2,4 Dinitrophenol as an Uncoupler Augments the Anthracyclines Toxicity against Prostate Cancer Cells 2,4 Dinitrophenol Wikipedia

SKU: 9833603203 · From southroadsurgery.com.au

4.6

USD28.93 USD71.93

Pay in 4 interest-free payments of $7.23 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 25 - Sep 30

Description

Plant Cell 28 , 160180 (2016)

dinitrophenol glutathione Thermoregulation in mitochondria: T = temperature change, q = heat S-(2,4-Dinitrophenyl)-Glutathione (Dinitrophenyl-S-Glutathione, GS-DNP, NSC 131112,

Lake, A

Are Vitamins HSA Eligible

A recent chemical proteomics study identified the pro-apoptotic Bcl-2 family protein BID as a direct covalent target of PEITC

Tirzepatide immunogenicity on pharmacokinetics, efficacy, and safety: analysis of data from phase 3 studies

However, development was discontinued in 2007 after the largest Phase IIb trial failed to demonstrate statistically significant weight loss compared to placebo